Researchers at the University of California, Santa Barbara, and UC San Francisco have identified molecular changes associated with menopause that correlate with brain aging, according to a study published in Nature Medicine. The research, conducted with international collaborators, analyzed proteomic data from pre-, peri-, and postmenopausal women, revealing increases in 16 molecules linked to brain aging and dementia risk. These shifts were more closely tied to menopause stage than chronological age, suggesting a biological connection between the transition and accelerated aging across organ systems.
The study examined thousands of proteins in cohorts from the Jacobs Lab’s Healthy Aging Study and confirmed findings in a UK Biobank dataset of 2,800 women. Researchers found that higher levels of specific “risk” proteins were associated with poorer cognitive outcomes and a modestly increased Alzheimer’s dementia risk over 16 years in 12,000 older women. The team aims to develop a blood test to detect these molecular signatures, similar to cholesterol testing, to identify midlife interventions for brain health. “Midlife is a critical window for both men and women where we can set up the brain to be more resilient or vulnerable to dementia,” said study senior author Kaitlin Casaletto.
Molecular Changes Linked to Menopause Transition
The study highlighted proteins involved in inflammatory and neuronal processes, as well as Alzheimer’s disease, that shift during menopause. Emily Jacobs, a professor of psychological and brain sciences at UCSB, emphasized that menopause is a “whole-body biological transition” with a molecular fingerprint detectable in blood. “Women spend roughly one third of their lives after the menopause transition, yet we know remarkably little about the biology connecting menopause to later-life brain health,” she said. The findings suggest menopause may serve as a pivotal point for studying brain aging and identifying resilience factors.
Study Confirms Links in Large Datasets
Results from the Healthy Aging Study and the UK Biobank showed that molecular signatures of accelerated aging were more strongly linked to menopause stages than age. The research team noted that while these protein changes do not directly cause dementia, they offer insights into biological processes beginning in midlife. “The findings do not mean that menopause causes Alzheimer’s disease,” Casaletto clarified. “Most women do not develop Alzheimer’s, and the clinical significance of individual protein changes remains uncertain.”
Potential for Early Dementia Risk Testing
The study’s authors proposed that tracking these molecular shifts could lead to early-warning tools for dementia risk. “These findings give us a new foothold for asking that question and ultimately for identifying who may benefit most from intervention during this critical window,” Jacobs said. The team called for longitudinal studies to further explore how hormonal, proteomic, and cognitive changes interact during menopause. Read the original study.
“Women spend roughly one third of their lives after the menopause transition, yet we know remarkably little about the biology connecting menopause to later-life brain health,” Jacobs said. “These findings give us a new foothold for asking that question and ultimately for identifying who may benefit most from intervention during this critical window.”
